Helsinki, Finland

Christopher Landowski

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Journey of Inventor Christopher Landowski

Introduction

Christopher Landowski, a notable inventor based in Helsinki, Finland, has made significant contributions to the field of biotechnology with a focus on the production of heterologous proteins. With a portfolio that boasts 11 patents, Landowski's work reflects a commitment to advancing scientific understanding and innovation.

Latest Patents

Among his most recent patent filings are "Protease deficient filamentous fungal cells and methods of use thereof." This disclosure relates to compositions and methods that are invaluable for producing heterologous proteins within filamentous fungal cells. The significance of these patents lies in their applications in various biotechnological processes, enhancing efficiency and effectiveness in protein production.

Career Highlights

Christopher Landowski has had a fruitful career, working with notable companies such as Glykos Finland Oy and VTT Technical Research Centre of Finland Ltd. His experiences in these organizations have played a vital role in shaping his innovative ideas and driving his research forward.

Collaborations

Landowski has collaborated with other talented individuals in the field, including colleagues Anne Huuskonen and Ann Westerholm-Parvinen. Their joint efforts have undoubtedly contributed to the patents and advancements that emerge from Landowski's innovative projects.

Conclusion

Christopher Landowski's dedication to innovation and research is evident in his numerous patents and partnerships. His focus on developing methods for the production of heterologous proteins in filamentous fungal cells positions him as a key figure in biotechnology, making significant strides that will benefit the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…